Trials / Completed
CompletedNCT02806570
The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study
Early Feasibility Study of the AccuCinch® Ventricular Restoration System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Ancora Heart, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, non-randomized, prospective Early Feasibility Study to evaluate the AccuCinch® Ventricular Restoration System in patients with symptomatic heart failure and concomitant functional mitral regurgitation that have stable symptoms on guideline-directed medical therapy
Detailed description
Device name changed from AccuCinch® Ventricular Repair System to AccuCinch® Ventricular Restoration System, FDA Approval Date 08Aug2020
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Mitral valve repair |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2020-01-01
- Completion
- 2024-08-22
- First posted
- 2016-06-20
- Last updated
- 2025-01-29
Locations
16 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02806570. Inclusion in this directory is not an endorsement.